New Published Study Suggests Calcium Fructoborate Improves Inflammatory Response, Lipid Markers, and Quality of Life.

November 19, 2012 MOMENCE,IL- FutureCeuticals, Inc. today announced publication of the results of a successful clinical study on Calcium Fructoborate, a patented plant mineral complex, on a large population of study participants.

The randomized, double-blind, active-controlled, parallel clinical trial evaluated the effects of short-term (60 days) oral supplementation with calcium fructoborate, resveratrol, and the combination thereof on the clinical and biological status of subjects with stable angina pectoris (chest pain or discomfort that usually occurs with activity or stress).

The results indicate that calcium fructoborate, alone and in combination with resveratrol, has beneficial effects for persons diagnosed with stable angina pectoris, including decreased angina episodes and improvement in quality of life. The study further indicates calcium fructoborate contributes to improvement in inflammatory conditions associated with cardiovascular conditions by significantly reducing levels of C-Reactive Protein (CRP) by up to 39.7%. Lipid markers (LDL and HDL) and total cholesterol were also improved in the calcium fructoborate and calcium fructoborate/resveratrol groups.

The results on CRP come on the heels of two recently-published studies indicating calcium fructoborate contributes to healthy inflammatory response by significantly reducing serum levels of CRP in humans. A previous human clinical trial also suggests calcium fructoborate supports cardiovascular health by lowering erythrocyte sedimentation rate (ESR), fibrinogen levels, and LDL and total cholesterol.

“FutureCeuticals is very pleased with the outcome of this study on one of our flagship ingredients,” said John Hunter, General Manager. “This study reaffirms earlier reports of calcium fructoborate’s important attributes for cardiovascular health and healthy inflammatory response and provides important clues in terms of why it has performed so well in the past. Inflammation has recently been associated with a number of human health conditions and may indeed be a primary factor in quality of life as we age. Knowing that calcium fructoborate exerts a significant effect on well-recognized, diagnostic markers of inflammation greatly expands its potential use in diverse nutritional supplement products.”

Source: Militaru C, et al., Nutrition (2012),

Oral resveratrol and calcium fructoborate supplementation in subjects with stable angina pectoris: Effects on lipid profiles, inflammation markers, and quality of life

About Calcium Fructoborate

Calcium Fructoborate is a patented mineral complex found in legumes, fruits, vegetables, herbs, and wine. The mineral complex has been the subject of over a dozen published studies on its unique properties and potential health benefits, especially for conditions linked to inflammation such as bone, joint, and cardiovascular conditions. Calcium Fructoborate is manufactured under US Patent #5,962,049 and issued and pending foreign patents and is available exclusively from VDF FutureCeuticals, Inc.  About FutureCeuticals, Inc.

FutureCeuticals, Inc. is a vertically integrated functional food ingredient, product development, and bioanalytical research and discovery company with farms and facilities inIllinois,Wisconsin,California, andEurope.

FutureCeuticals is a voting member of the Council for Responsible Nutrition, a voting member of the International Probiotics Association, and a member of the American Botanical Council.